Business & Regulation

After a new approval and multi-million dollar deals, are ADCs finally moving to the forefront in the targeted therapy space?

The EMA has granted conditional marketing approval for Ervebo, the first vaccine to protect against Ebola.

Tony Hitchcock discusses his career and the evolution of the gene therapy market.

Brexit is a serious challenge for UK businesses trading with the EU.

Drug pricing concerns, facility expansions and regulatory changes... What’s new for pharma in business?

Single-use biotech process equipment is already making use of technology to automate processes and the level of complexity is increasing.

Sitting Down With… Charles Gore, Executive Director, Medicines Patent Pool (MPP), Geneva, Switzerland.

Rethinking our approach to the use of energy and resources could help transform our relationship with the environment.

Can’t offer an “affordable” price? Then say goodbye to market exclusivity.

Joe Biden apparently dared say there were “great drug companies out there – except for a couple of opioid outfits.”